Time Course of Microbiologic Outcome and Gene Expression in Candida albicans during and following In Vitro and In Vivo Exposure to Fluconazole

Abstract

Pharmacodynamics (PD) considers the relationship between drug exposure and effect. The two factors that have been used to distinguish the PD behaviors of antimicrobials are the impact of concentration on the extent of organism killing and the duration of persistent microbiologic suppression (postantibiotic effect). The goals of these studies were (i) to examine the relationship between antimicrobial PD and gene expression and (ii) to gain insight into the mechanism of fluconazole effects persisting following exposure. Microarrays were used to estimate the transcriptional response of Candida albicans to a supra-MIC F exposure over time in vitro. Fluconazole at four times the MIC was added to a log-phase C. albicans culture, and cells were collected to determine viable growth and for microarray analyses. We identified differential expression of 18% of all genes for at least one of the time points. More genes were upregulated (n ‫؍‬ 1,053 [16%]) than downregulated (174 [3%]). Of genes with known function that were upregulated during exposure, most were related to plasma membrane/cell wall synthesis (18%), stress responses (7%), and metabolism (6%). The categories of downregulated genes during exposure included protein synthesis (15%), DNA synthesis/repair (7%), and transport (7%) genes. The majority of genes identified at the postexposure time points were from the protein (17%) and DNA (7%) synthesis categories. In subsequent studies, three genes (CDR1, CDR2, and ERG11) were examined in greater detail (more concentration and time points) following fluconazole exposure in vitro and in vivo. Expression levels from the in vitro and in vivo studies were congruent. CDR1 and CDR2 transcripts were reduced during in vitro fluconazole exposure and during supra-MIC exposure in vivo. However, in the postexposure period, the mRNA abundance of both pumps increased. ERG11 expression increased during exposure and fell in the postexposure period. The expression of the three genes responded in a dose-dependent manner. In sum, the microarray data obtained during and following fluconazole exposure identified genes both known and unknown to be affected by this drug class. The expanded in vitro and in vivo expression data set underscores the importance of considering the time course of exposure in pharmacogenomic investigations.The time course of antimicrobial activity is dependent on a drug's pharmacokinetics and two major pharmacodynamic characteristics (2, 13). The first is the rate of organism killing and whether increasing drug concentrations enhance the rate and extent of killing. The second is the presence or absence of inhibitory effects on organism growth which persist after drug levels have fallen below the MIC. These persistent effects are termed postantibiotic effects (PAE) (3,4,5,9,14,16,29,38,39,40). The PAE pharmacodynamic phenomenon underscores the importance of investigating the effects of antimicrobial exposure over time. Drugs from the triazole class demonstrate time-dependent killing but prolonged persistent effects...

Azole Resistance of Aspergillus fumigatus Biofilms Is Partly Associated with Efflux Pump Activity

“…Similarly, the expression of CaMDR1 in a catheter-based C. albicans biofilm model has been reported, but at a lower constitutive level (26). Moreover, the same group reported induction of CaCDR1 and CaCDR2 in their in vivo model following fluconazole treatment but no change in the expression of CaMDR1 (11).…”

Role of Ndt80p in Sterol Metabolism Regulation and Azole Resistance in Candida albicans

“…Likewise, 10 upregulated genes were common with those of our study, including 8 ERG genes (ERG1, ERG3, ERG4, ERG5, ERG6, ERG7, ERG11, ERG251) and also the fatty acyl coenzyme A synthase FAS2. These findings suggests that, even when using different strains and growth and treatment conditions on different microarray platforms, C. albicans responds to fluconazole by activating mainly the ergosterol pathway, as was indeed demonstrated by several fungi following the exposure to other azole drugs (1,12,7,27,28). In the wild-type strain, upregulation of ERG genes is considered to be VOL.…”

Potent Synergistic Effect of Doxycycline with Fluconazole against Candida albicans Is Mediated by Interference with Iron Homeostasis

“…While elevated dosage of doxycycline alone has a negative impact on growth of the reference strain SC5314 (without reaching the MIC), presumably by iron depletion, clinical strain FH5 is insensitive to these conditions, suggesting that the ability of this strain to thrive in a low-iron environment and resistance to fluconazole may be linked. Interestingly, transcription of the iron transporters FRE9 and FTR1-the latter required for growth under low-iron conditions (51)-is upregulated in response to exposure to fluconazole (27).…”